Hextar Healthcare Berhad Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Hextar Healthcare Berhad.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Household Products earnings growth	13.8%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Optimistic Investors Push Hextar Healthcare Berhad (KLSE:HEXCARE) Shares Up 47% But Growth Is Lacking

Dec 18

The Returns At Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Aren't Growing

Aug 30

We Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Have The DNA Of A Multi-Bagger

May 27

Returns On Capital Are A Standout For Rubberex Corporation (M) Berhad (KLSE:RUBEREX)

Feb 26

Should You Investigate Rubberex Corporation (M) Berhad (KLSE:RUBEREX) At RM0.57?

Nov 17

If You Like EPS Growth Then Check Out Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Before It's Too Late

May 11

What Is Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Share Price Doing?

Apr 12

Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Mar 02

Here's Why I Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Deserve Your Attention Today

Feb 09

Under The Bonnet, Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Returns Look Impressive

Jan 22

How Much Of Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Do Insiders Own?

Jan 04

If You Had Bought Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Stock A Year Ago, You Could Pocket A 780% Gain Today

Dec 17

Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Is Growing Earnings But Are They A Good Guide?

Dec 02

Declining Stock and Decent Financials: Is The Market Wrong About Rubberex Corporation (M) Berhad (KLSE:RUBEREX)?

Nov 18

What Does Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) CEO Pay Reveal?

Jul 14

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Hextar Healthcare Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KLSE:HEXCARE - Analysts future estimates and past financials data (MYR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	155	-66	-21	-21	N/A
9/30/2023	163	-74	-26	-15	N/A
6/30/2023	153	-69	-23	-9	N/A
3/31/2023	159	-61	-20	-5	N/A
12/31/2022	179	-56	-35	-20	N/A
9/30/2022	203	10	-51	-16	N/A
6/30/2022	262	39	-23	7	N/A
3/31/2022	392	102	21	56	N/A
12/31/2021	515	186	99	134	N/A
9/30/2021	600	236	132	198	N/A
6/30/2021	614	250	150	216	N/A
3/31/2021	525	208	146	208	N/A
12/31/2020	417	131	80	141	N/A
9/30/2020	315	76	57	88	N/A
6/30/2020	268	39	-1	31	N/A
3/31/2020	235	19	-32	-1	N/A
12/31/2019	219	11	8	39	N/A
9/30/2019	208	11	20	39	N/A
6/30/2019	202	10	44	62	N/A
3/31/2019	204	10	51	70	N/A
12/31/2018	205	9	25	44	N/A
9/30/2018	68	7	29	45	N/A
6/30/2018	117	7	27	44	N/A
3/31/2018	159	8	23	40	N/A
12/31/2017	188	10	27	44	N/A
9/30/2017	374	17	N/A	17	N/A
6/30/2017	341	19	N/A	29	N/A
3/31/2017	317	21	N/A	22	N/A
12/31/2016	311	21	N/A	25	N/A
9/30/2016	302	17	N/A	49	N/A
6/30/2016	305	16	N/A	24	N/A
3/31/2016	304	16	N/A	26	N/A
12/31/2015	300	15	N/A	25	N/A
9/30/2015	296	11	N/A	29	N/A
6/30/2015	298	10	N/A	45	N/A
3/31/2015	296	10	N/A	49	N/A
12/31/2014	296	10	N/A	49	N/A
9/30/2014	304	9	N/A	43	N/A
6/30/2014	319	6	N/A	44	N/A
3/31/2014	323	3	N/A	45	N/A
12/31/2013	325	0	N/A	45	N/A
9/30/2013	321	5	N/A	36	N/A
6/30/2013	329	13	N/A	33	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if HEXCARE's forecast earnings growth is above the savings rate (3.5%).

Earnings vs Market: Insufficient data to determine if HEXCARE's earnings are forecast to grow faster than the MY market

High Growth Earnings: Insufficient data to determine if HEXCARE's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if HEXCARE's revenue is forecast to grow faster than the MY market.

High Growth Revenue: Insufficient data to determine if HEXCARE's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if HEXCARE's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Hextar Healthcare Berhad Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Full year 2023 earnings released: RM0.066 loss per share (vs RM0.062 loss in FY 2022)

New major risk - Share price stability

Hextar Healthcare Berhad Announces the Resignation of Lim Chee Lip, as Executive Director

Optimistic Investors Push Hextar Healthcare Berhad (KLSE:HEXCARE) Shares Up 47% But Growth Is Lacking

Third quarter 2023 earnings released: RM0.01 loss per share (vs RM0.005 loss in 3Q 2022)

New minor risk - Share price stability

Hextar Healthcare Berhad Appoints Mastura Binti Muhamad as Company Secretary

Second quarter 2023 earnings released: RM0.006 loss per share (vs RM0.002 profit in 2Q 2022)

First quarter 2023 earnings released: RM0.003 loss per share (vs RM0.003 profit in 1Q 2022)

Hextar Healthcare Berhad Announces Appointment of Sim Yee Fuan as Independent and Non Executive Member of Nomination and Remuneration Committee

Full year 2022 earnings released: RM0.063 loss per share (vs RM0.22 profit in FY 2021)

High number of new and inexperienced directors

Hextar Healthcare Berhad Appoints Lim Siew Eng as Independent and Non Executive Member of Nomination and Remuneration Committee, Effective from January 1, 2023

Hextar Healthcare Berhad Announces Appointment of Wong Yee Leng as Company Secretary

Third quarter 2022 earnings released: RM0.005 loss per share (vs RM0.03 profit in 3Q 2021)

High number of new directors

Rubberex Corporation (M) Berhad (KLSE:RUBEREX) completed the acquisition of Reszon Diagnostics International Sdn. Bhd. from Revongen Corporation Sdn Bhd and Law Eng Lim.

The Returns At Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Aren't Growing

Second quarter 2022 earnings released: EPS: RM0.002 (vs RM0.078 in 2Q 2021)

Rubberex Corporation (M) Berhad (KLSE:RUBEREX) agreed to acquire Reszon Diagnostics International Sdn. Bhd. from Revongen Corporation Sdn Bhd and Law Eng Lim for RMB 180 million.

We Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Have The DNA Of A Multi-Bagger

Full year 2021 earnings: EPS and revenues miss analyst expectations

High number of new directors

Returns On Capital Are A Standout For Rubberex Corporation (M) Berhad (KLSE:RUBEREX)

Full year 2021 earnings: EPS and revenues miss analyst expectations

Rubberex Corporation (M) Berhad Announces Redesignation of Mohamed Bin Hamzah from Member of Nomination Committee to Chairman of Nomination Committee

Third quarter 2021 earnings: EPS and revenues miss analyst expectations

Should You Investigate Rubberex Corporation (M) Berhad (KLSE:RUBEREX) At RM0.57?

Independent Non Executive Director Mustapha Bin Mohamed has left the company

High number of new directors

Second quarter 2021 earnings released: EPS RM0.078 (vs RM0.028 in 2Q 2020)

Director Jee Liew has joined 5th company board

First quarter 2021 earnings released: EPS RM0.10 (vs RM0.012 in 1Q 2020)

If You Like EPS Growth Then Check Out Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Before It's Too Late

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS RM0.16 (vs RM0.015 in FY 2019)

What Is Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Share Price Doing?

Investor sentiment improved over the past week

Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Revenue and earnings miss expectations

Full year 2020 earnings released: EPS RM0.16 (vs RM0.015 in FY 2019)

New 90-day low: RM1.30

Investor sentiment deteriorated over the past week

Here's Why I Think Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Might Deserve Your Attention Today

Under The Bonnet, Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) Returns Look Impressive

Investor sentiment improved over the past week

How Much Of Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Do Insiders Own?

New 90-day low: RM1.35

If You Had Bought Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Stock A Year Ago, You Could Pocket A 780% Gain Today

New 90-day low: RM1.54

Market pulls back on stock over the past week

Rubberex Corporation (M) Berhad (KLSE:RUBEREX) Is Growing Earnings But Are They A Good Guide?

Third quarter 2020 earnings released: EPS RM0.05

Declining Stock and Decent Financials: Is The Market Wrong About Rubberex Corporation (M) Berhad (KLSE:RUBEREX)?

Market pulls back on stock over the past week

Rubberex Corporation (M) Berhadd Announces the Appointment of Chan Choun Sien, Independent and Non Executive as Member of Remuneration Committee

Market bids up stock over the past week

Market pulls back on stock over the past week

New 90-day high: RM7.40

First half earnings released

Erpstar Inc. Sdn. Bhd. completed the offer to acquire an additional 0.96% stake in Rubberex Corporation (M) Berhad (KLSE:RUBEREX) for approximately MYR 4.8 million.

Erpstar Inc. Sdn. Bhd acquired 20.63% stake in Rubberex Corporation (M) Berhad (KLSE:RUBEREX) from Seng Sheng Enterprise Sdn Bhd, Dautk Seri Chiau Beng Teik and Peh Lian Hwa for approximately MYR 100 million

New 90-day high - RM4.59

What Does Rubberex Corporation (M) Berhad's (KLSE:RUBEREX) CEO Pay Reveal?

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies